Inspirion Wealth Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$236K Buy
+350
New +$208K 0.03% 167
2026
Q1
– Sell
-350
Closed -$203K – 187
2025
Q4
$203K Hold
350
– – 0.02% 163
2025
Q3
$217K Buy
+350
New +$163K 0.03% 143
2024
Q4
– Sell
-350
Closed -$217K – 163
2024
Q3
$217K Buy
+350
New +$207K 0.03% 144
2024
Q2
– Sell
-350
Closed -$203K – 154
2024
Q1
$203K Buy
+350
New +$196K 0.03% 142
2023
Q2
– Sell
-427
Closed -$246K – 147
2023
Q1
$246K Buy
+427
New +$241K 0.05% 120
2022
Q2
– Sell
-350
Closed -$207K – 125
2022
Q1
$207K Hold
350
– – 0.04% 102
2021
Q4
$234K Hold
350
– – 0.05% 93
2021
Q3
$200K Buy
+350
New +$192K 0.05% 88

Other funds holding TMO

Inspirion Wealth Advisors's TMO Position: Q3 2026 in Review

Inspirion Wealth Advisors opened a new position in Thermo Fisher Scientific (TMO) in Q3 2026: 350 shares worth $236K. The stake represents 0.03% of the portfolio and ranks #167 among its holdings. This is a return to the name: Inspirion Wealth Advisors previously reported a position in TMO as recently as Q4 2025.

Inspirion Wealth Advisors first reported a position in TMO in Q3 2021 and has held it in 9 quarters since. The position peaked at $246K in Q1 2023. 134 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • Inspirion Wealth Advisors held 350 shares of Thermo Fisher Scientific worth $236K as of Q3 2026.
  • Thermo Fisher Scientific was a new Inspirion Wealth Advisors position in Q3 2026.
  • Thermo Fisher Scientific made up 0.03% of Inspirion Wealth Advisors's portfolio in Q3 2026, its #167 holding.
  • Inspirion Wealth Advisors first reported a position in Thermo Fisher Scientific in Q3 2021 and has held it in 9 quarters since.
  • Inspirion Wealth Advisors's Thermo Fisher Scientific position peaked at $246K in Q1 2023.
  • 134 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Inspirion Wealth Advisors's 13F filing for Q3 2026, filed 9 Oct 2026.